CytoSorbents • CTSO
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Phillip P. Chan, M.D.,Pd.D$43.5M
Market Cap • 18/04/20242014
(há 10 anos)
2005
(19 years ago)
NASDAQ
Listagem
Princeton
Sede • New Jersey221
N° de Empregados • 2021Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CTSOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.